# Giorgio Sesti

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giorgio-sesti/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,279 |
| Field | Diabetes Treatment and Management |
| h-index | 78 |
| i10-index | 345 |
| Last Known Institution | Sapienza University of Rome |
| OpenAlex ID | https://openalex.org/A5084623347 |
| ORCID iD | https://orcid.org/0000-0002-1618-7688 |
| Works | 591 |

## Researcher papers

- [Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)](https://scholariq.org/papers/liraglutide-once-a-day-versus-exenatide-twice-a-day-for-type-2-diabetes-a-26/)
- [Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells](https://scholariq.org/papers/insulin-dependent-activation-of-endothelial-nitric-oxide-synthase-is-impaired-by/)
- [Defects of the insulin receptor substrate (IRS) system in human metabolic disorders](https://scholariq.org/papers/defects-of-the-insulin-receptor-substrate-irs-system-in-human-metabolic/)
- [Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial](https://scholariq.org/papers/effects-on-the-incidence-of-cardiovascular-events-of-the-addition-of/)
- [Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): <scp>D</scp> ata from randomized controlled trials](https://scholariq.org/papers/safety-issues-with-glucagon-like-peptide-1-receptor-agonists-pancreatitis/)
- [Review of methods for detecting glycemic disorders](https://scholariq.org/papers/review-of-methods-for-detecting-glycemic-disorders/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

## Researcher university

- [Sapienza University of Rome](https://scholariq.org/institutions/sapienza-university-of-rome/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.